Evidence map›Paper›PMID 34922259›Full record

ArticleAmerican journal of otolaryngology

The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease.

Osman Durgut, Mesut Karataş, Çağlar Çelik, Oğuzhan Dikici, Fevzi Solmaz, Sündüz Gencay

Open access · greenAbstract read
In one paragraph

Article in American journal of otolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Impact of COVID-19 Medication (Favipiravir and Hydroxychloroquine) on High Frequency Hearing.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Osman DurgutDepartment of Otorhinolaryngology, Health Science University, Bursa Yuksek Ihtisas Training and Research Hospital, Turkey. Electronic address: durgutosman@yahoo.com.
Mesut KarataşDepartment of Otorhinolaryngology, Health Science University, Bursa Yuksek Ihtisas Training and Research Hospital, Turkey.
Çağlar ÇelikDepartment of Otorhinolaryngology, Health Science University, Bursa Yuksek Ihtisas Training and Research Hospital, Turkey.
Oğuzhan DikiciDepartment of Otorhinolaryngology, Health Science University, Bursa Yuksek Ihtisas Training and Research Hospital, Turkey.
Fevzi SolmazDepartment of Otorhinolaryngology, Health Science University, Bursa Yuksek Ihtisas Training and Research Hospital, Turkey.
Sündüz GencayDepartment of Otorhinolaryngology, Health Science University, Bursa Yuksek Ihtisas Training and Research Hospital, Turkey.
Sağlık Bilimleri Üniversitesi · TRBursa Yuksek Ihtisas Egitim Ve Arastirma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 may have many nonspecific symptoms, such as hearing loss, tinnitus and dizziness. This study aims to investigate the effects of SARS-CoV-2 on the hearing thresholds of patients with COVID-19.

methodsA total of 20 patients aged 20-55 years who were diagnosed with COVID-19 were included in this study. The relationship between the pure-tone thresholds of patients before and after COVID-19 was evaluated.

resultsThere was no statistically significant difference between bone conduction pure-tone thresholds in all frequencies before and after COVID-19.

conclusionSARS-CoV-2 has no effects on the hearing thresholds in patients with non-hospitalized mild COVID-19 disease. Further studies are needed to investigate the possible effects of SARS-CoV-2 on the auditory system.

Indexed as

COVID-19Hearing LossAdultAudiometry, Pure-ToneAuditory ThresholdHearingHumansMiddle AgedSARS-CoV-2Young AdultCOVID-19Hearing lossPandemicSARS-CoV-2

Identifiers

PMID34922259
PMCPMC8669941
OpenAlexW4200412326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.